Vanda Pharmaceuticals Reports Second Quarter 2014 Results
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced...
Par Pharmaceutical Announces Quarterly Conference Call
Par Pharmaceutical Companies, Inc. announced today that it will host a conference call on Wednesday, August 13, 2014 at 10:00 a.m. EDT to review...
Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014
Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and financial results for the second quarter...
NPS Pharma Reports Second-Quarter 2014 Financial Results
NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare diseases, today reported its...
Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending June 30, 2014. The...
PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
PTC Therapeutics, Inc. today announced a corporate update and reported financial results for the second quarter ended June 30, 2014. "This has been...
Hill-Rom Reports Improved Fiscal Third Quarter Results; Updates Full-Year Guidance
-- Third quarter revenue of $398 million declined 6 percent versus prior year -- Adjusted diluted earnings per share for the third quarter of...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...